The proposed research will characterize the processes creating and sustaining beliefs about herpes and the stigma associated with it, as a basis for an intervention designed to produce more rational herpes-related decision-making. Stigma can interfere with the sort of instrumental cost-benefit and risk-benefit thinking that many informational interventions attempt to augment. An intervention that decreased the stigma associated with genital herpes may result in better communication with sexual partners, more rational decision-making, and better quality of life for the 200,000 to 500,000 persons who contract genital herpes each year. This project will examine young adults' mental models of genital herpes infections, including transmission, treatment, symptoms, peer detection, medical diagnosis, and prevention. Particular attention will be given to perceptions of stigma. Such beliefs and emotions will be explored among individuals with three different personal relationships to the disease: (a) recently diagnosed with genital herpes, (b) long-established infections, and (c) no known genital herpes. We will develop two standardized instruments related to genital herpes, based on interview results. The first will provide a measure of the stigma associated with herpes injections. It is expected that the key elements of this instrument will include personal feelings of self-worth, perceptions of outside opinion about people with herpes, both psychologically and sexually as well as fear of transmitting (or contracting) herpes. The second instrument will cover knowledge of genital herpes. It will concentrate on those issues that are most critical to making herpes-related decisions (as revealed in a formal analysis), and those misconceptions or knowledge gaps revealed in the interviews. We will develop and evaluate an intervention designed to decrease the stigma associated with herpes diagnosis. It will use interactive video technology, in order to provide the intensity and personalization that such topics require. Its evaluation will test whether the intervention succeeds in (a) decreasing stigma in newly diagnosed individuals, (b) decreasing the stigma associated with herpes in uninfected individuals, and (c) increasing social functioning in infected individuals, including increased communication with their sexual partners about potential STD infections. The decrease in stigma and increase in communication are expected to result in more condom use when engaging in sexual behavior.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI047785-02
Application #
6340746
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
$84,558
Indirect Cost
Name
Magee-Women's Hospital of Upmc
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Cook, Robert L; Downs, Julie S; Marrazzo, Jeanne et al. (2009) Preferred characteristics of vaginal microbicides in women with bacterial vaginosis. J Womens Health (Larchmt) 18:1163-7
Bunge, Katherine E; Beigi, Richard H; Meyn, Leslie A et al. (2009) The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis 36:711-3
Antonio, May A D; Meyn, Leslie A; Murray, Pamela J et al. (2009) Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 199:1506-13
Beigi, Richard H; Yudin, Mark H; Cosentino, Lisa et al. (2007) Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis 196:1355-60
Marrazzo, Jeanne M; Wiesenfeld, Harold C; Murray, Pamela J et al. (2006) Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 193:617-24
Marrazzo, Jeanne M; Cook, Robert L; Wiesenfeld, Harold C et al. (2006) Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt) 15:1053-60
Kwok, Louisa; Stapleton, Ann E; Stamm, Walter E et al. (2006) Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urol 176:2050-4; discussion 2054
Austin, M N; Beigi, R H; Meyn, L A et al. (2005) Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 43:4492-7
Antonio, May A D; Rabe, Lorna K; Hillier, Sharon L (2005) Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 192:394-8
Beigi, Richard H; Austin, Michele N; Meyn, Leslie A et al. (2004) Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191:1124-9

Showing the most recent 10 out of 15 publications